ENMD-2076 T2358
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFR_.
CAS nr:
934353-76-1
Purity:
98%
Molecular Weight:
375,47
SMILES:
Cc1cc(n[nH]1)Nc1nc(nc(c1)N1CCN(CC1)C)/C=C/c1ccccc1
Formula:
C21H25N7
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Chromatin/Epigenetic,Cell Cycle/Checkpoint,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis,Tyrosine Kinase/Adaptors
Target:
PDGFR,PDGFR,FLT,c-RET,VEGFR,VEGFR,c-RET,Aurora Kinase,Aurora Kinase,Src,Src,FGFR,FGFR,Apoptosis,FLT
